Skip to main content
. 2024 Jan 22;78(6):1732–1744. doi: 10.1093/cid/ciae010

Figure 2.

Figure 2.

Flow of participants. Abbreviations: ICF, informed consent form; N, number of participants; n, number of participants eliminated; placebo, group of participants randomized to receive placebo pre-season 1 and 2; R, randominzation (1:1); RSV, respiratory syncytial virus; RSV-ARI, RSV-related acute respiratory illness; RSV_1dose, group of participants who received a dose of RSV prefusion F protein-based vaccine (RSVPreF3 OA) pre–season 1 and were randomized to receive a placebo dose pre–season 2; RSVPreF3 OA, group of participants randomized to receive a dose of RSVPreF3 OA pre–RSV season 1; RSV_revaccination, group of participants who received a first dose of RSVPreF3 OA pre–season 1 and were randomized to receive a second RSVPreF3 OA dose (revaccination) pre–season 2.